共 50 条
- [32] Prescribing Recommendations For Interferon-Beta In Multiple Sclerosis CNS Drugs, 1997, 8 : 102 - 112
- [34] Therapeutic Plasma Exchange in Multiple Sclerosis Patients with Abolished Interferon-beta Bioavailability MEDICAL SCIENCE MONITOR, 2015, 21 : 1512 - 1519
- [35] Use of MxA mRNA and neutralising antibodies detection as predictive factors of interferon beta clinical efficacy in multiple sclerosis patients MULTIPLE SCLEROSIS, 2006, 12 : S206 - S206
- [36] Baseline MxA mRNA Expression Predicts Interferon Beta Response in Multiple Sclerosis Patients PLOS ONE, 2014, 9 (11):
- [38] Immune response to immunotherapy:: the role of neutralising antibodies to interferon beta in the treatment of multiple sclerosis LANCET NEUROLOGY, 2005, 4 (07): : 403 - 412
- [40] Neutralising antibodies to interferon beta during the treatment of multiple sclerosis JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2002, 73 (05): : 465 - 469